Nathalie Dartois

23-25 Avenue Du Dr. Lannelongue, F-75668 Paris Cedex 14
Paris, 75668, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.

Journal: Respiratory medicine

Published: December 01, 2017

Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination.

Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination.

Journal: European journal of internal medicine

Published: May 21, 2016

A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in Canada.

A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in Canada.

Journal: Canadian respiratory journal

Published: December 16, 2015

PCVs in individuals at increased risk of pneumococcal disease: a literature review.

PCVs in individuals at increased risk of pneumococcal disease: a literature review.

Journal: Expert review of vaccines

Published: June 18, 2015

A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada.

A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada.

Journal: Canadian respiratory journal

Published: May 28, 2015

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Journal: Thorax

Published: January 07, 2015

Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005-2010).

Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005-2010).

Journal: Medecine et maladies infectieuses

Published: December 08, 2014

A retrospective study of hospitalized pneumonia in two Polish counties (2006-2008).

A retrospective study of hospitalized pneumonia in two Polish counties (2006-2008).

Journal: Pneumonologia i alergologia polska

Published: August 22, 2013

Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.

Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.

Journal: Antimicrobial agents and chemotherapy

Published: January 30, 2013

Tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia: an analysis of risk factors.

Tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia: an analysis of risk factors.

Journal: The open respiratory medicine journal

Published: August 31, 2012

Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline.

Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline.

Journal: Antimicrobial agents and chemotherapy

Published: December 07, 2011

Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia.

Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia.

Journal: Antimicrobial agents and chemotherapy

Published: October 05, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026